Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity / (Deficit) (Tables)

v3.20.2
Shareholders' Equity / (Deficit) (Tables)
9 Months Ended
Sep. 30, 2020
Reconciliation of the Company's Beginning and Ending Balances in Shareholders' Equity / (Deficit)

The following tables present a reconciliation of the Company’s beginning and ending balances in shareholders’ equity / (deficit) for the nine months ended September 30, 2020 and 2019:

 

 

 

Total

Shareholders'

Deficit

 

Shareholders' deficit at January 1, 2020

 

$

(26,238

)

Share-based compensation expense

 

 

2,633

 

Issuance of ordinary shares, net

 

 

5,326

 

Issuance of warrants

 

 

3,196

 

Net loss

 

 

(40,820

)

Shareholders' deficit at September 30, 2020

 

$

(55,903

)

 

 

 

Total

Shareholders'

Equity / (Deficit)

 

Shareholders' equity at January 1, 2019

 

$

71,622

 

Issuance of ordinary shares

 

 

3,037

 

Exercise of share options

 

 

60

 

Share-based compensation expense

 

 

1,674

 

Net loss

 

 

(79,489

)

Shareholders' deficit at September 30, 2019

 

$

(3,096

)

Schedule of Financial Assets Measured at Fair Value

The following table presents information about the Company’s financial assets that were carried at fair value on a recurring basis on the condensed consolidated balance sheet as of September 30, 2020 and December 31, 2019 and indicates the fair value hierarchy of the valuation inputs utilized to determine such fair value.

 

September 30, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Other asset – advance payment to supplier

 

$

3,919

 

 

 

 

 

 

 

 

 

3,919

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Other asset – advance payment to supplier

 

$

3,884

 

 

 

 

 

 

 

 

 

3,884

 

Warrant  
Schedule of Financial Assets Measured at Fair Value

The Company has classified the warrants as equity in accordance with ASC 815. The fair value of the warrants were valued at issuance using the Black-Scholes option pricing model with the following assumptions: 

 

 

 

June 5, 2020

 

Volatility

 

 

120

%

Expected term in years

 

2.50 - 2.75

 

Dividend rate

 

 

0

%

Risk-free interest rate

 

 

0.47

%

Share price

 

$

1.53

 

Fair value of warrants issued

 

$0.92 -$1.03

 

The Company has classified the warrants as equity in accordance with ASC 815. The fair value of the warrants were valued at issuance using the Black-Scholes option pricing model with the following assumptions: 

 

 

 

July 02, 2020

 

Volatility

 

 

120

%

Expected term in years

 

2.50 - 2.75

 

Dividend rate

 

 

0

%

Risk-free interest rate

 

 

0.47

%

Share price

 

$

1.19

 

Fair value of warrants issued

 

$0.69 -$0.78